CEO sentenced 2.8 years for share price manipulation scheme
Genetic Technologies Limited · Biotechnology / Genomics
The case in brief
Visible before detection
Checks that could have surfaced it, on hindsight
Bank credits vs books
Margin loan drawdowns and repayments tied to share price movements
Can mislead when: AA only sees the accounts the company links, so an undisclosed account stays invisible. Cash-heavy businesses and timing differences create false flags.
Third-party confirmation
Broker statements confirming margin loan positions and call activity
Can mislead when: Counterparties can collude or ignore requests. A non-response is logged as a gap, never as a pass.
Operating-metric verification
Share trading volume anomalies and unusual order patterns during margin call periods
Can mislead when: Contract staff do not appear in EPFO. Vahan access needs licensed APIs. Some businesses have no physical trace.
Where Kubr services would have helped
Financial diligence
Offered in India- C1 Margin loan drawdowns and repayments tied to share price movements
- C10 Share trading volume anomalies and unusual order patterns during margin call periods
Model check
Offered in India- C1 Margin loan drawdowns and repayments tied to share price movements
- C10 Share trading volume anomalies and unusual order patterns during margin call periods
Valuation context
Offered in India- Peer multiples and the exit-multiple bridge would have shown how much of the story relied on valuation holding.
Portfolio monitor
Offered in India- C1 Margin loan drawdowns and repayments tied to share price movements
- C10 Share trading volume anomalies and unusual order patterns during margin call periods
Mapped from the checks each service runs. A hindsight reading of public records, not a promise that the failure would have been found.
Same pattern
A summary of public documents. It reports what the sources say. It is not Kubr's finding and not a statement of guilt.